Anne Sissel
Vice President, Strategic Initiatives Advanced Surgery @ Baxter Ventures
Chicago, United States
Anne Sissel is a Series C investor at Baxter Ventures in Chicago focused on Analytics and Wearables. Anne E. Sissel has been Managing Director of Baxter Ventures and also serves as its Vice President and Head. Anne Sissel was a Vice President, Head of Finance and Business Development and Chief Financial Officer for Veracyte, Inc. Anne Sissel also served as the Senior Director of Finance and Business Development at Veracyte, Inc. As an InvestmentBanker with Goldman, Sachs & Co., she focused on mergers and acquisitions and completed over 15 transactions. Anne Sissel served as an Associate with the Corporate Value Consulting group of PricewaterhouseCoopers LLP. While there, she completed numerous equity valuation and acquisition advisory assignments for clients in the healthcare and consumer products industries. Anne Sissel served as Non-Executive Director of Gliknik, Inc. Anne Sissel has completed over $200 billion in mergers and acquisitions and financing transactions in the healthcare sector. She has transaction and analytical support to senior bankers on a variety of engagements, including mergers and acquisitions, strategic advisory services and strategic capital planning. Anne Sissel has 10 years of experience in finance and investment banking. She is a Chartered Financial Analyst Charter holder. She serves as Board Observer at Laboratoris Sanifit S.L. Anne Sissel earned her B.S. degree in Finance and International Business from Indiana University and an M.B.A. in Health Care Management from the Wharton School of the University of Pennsylvania.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Anne Sissel invests in
Stages Anne Sissel invests in
Countries Anne Sissel invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Analytics 1 (100%)
- Wearables 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
VitalConnect
|
VitalConnect develops wearable biosensor technology designed for wireless patient monitoring. It leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms. The company's products are designed for inpatient and outpatientsettings, such as hospital monitoring, post-discharge care, cardiac monitoring, and pharmaceutical solutions. | $38M / Series C / Oct 31, 2017 |
Co-Investors
About Baxter Ventures
Baxter Ventures invests in companies with innovative technologies, products and therapies with the ability to improve patient care globally and maximize value for investors and entrepreneurs. Our focus includes therapeutic areas complementary to those of Baxter's Medical Products and BioScience businesses, as well as cutting-edge technologiesand therapies outside of our current product portfolio that have sustainable long-term growth potential.As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to develop products and therapies that advance patient care worldwide.
Baxter Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anne Sissel
Vice President, Strategic Initiatives Advanced Surgery
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Anne Sissel invest in?
Anne Sissel invests primarily in Analytics, Wearables and Health Care startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Anne Sissel?
Public channels for Anne Sissel include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Anne Sissel last invest?
The most recent investment recorded for Anne Sissel closed in Oct 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
